相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interactive visual analysis of drug-target interaction networks using Drug Target Profiler, with applications to precision medicine and drug repurposing
Ziaurrehman Tanoli et al.
BRIEFINGS IN BIOINFORMATICS (2020)
Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia
Brent M. Kuenzi et al.
SCIENTIFIC REPORTS (2019)
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
Michael P. Menden et al.
NATURE COMMUNICATIONS (2019)
Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery
Balaguru Ravikumar et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients
Liye He et al.
CANCER RESEARCH (2018)
Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions
Jing Tang et al.
CELL CHEMICAL BIOLOGY (2018)
High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells
Arun Sharma et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A Data-Driven Approach to Predicting Successes and Failures of Clinical Trials
Kaitlyn M. Gayvert et al.
CELL CHEMICAL BIOLOGY (2016)
High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes
Fabian Alexander Grimm et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2015)
Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation
Tea Pemovska et al.
NATURE (2015)
Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
Tea Pemovska et al.
CANCER DISCOVERY (2013)
Targeting the cancer kinome through polypharmacology
Zachary A. Knight et al.
NATURE REVIEWS CANCER (2010)
分享论文
